NCT00797511View on ClinicalTrials.gov

Immunogenicity and Safety of Adacel Polio Vaccine

PHASE3CompletedINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

April 30, 2009

Study Completion Date

July 31, 2009

Conditions
DiphtheriaTetanusPertussisPoliomyelitis
Interventions
BIOLOGICAL

TdcP-IPV vaccine

0.5 mL, Intramuscular

Trial Locations (1)

100

Taipei

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00797511 - Immunogenicity and Safety of Adacel Polio Vaccine | Biotech Hunter | Biotech Hunter